The phases of a study

Almost every listing names a phase. It tells you how far along a treatment is, and it hints at what the study will ask of you.

Why studies come in phases

A new medicine is never tested on a large group straight away. Each phase answers a narrower question with more people than the one before, and a treatment moves on only if the earlier results justify it. Many treatments stop along the way, which is the system working as intended.

The four phases, in order

01
Phase 1
A small group, often healthy volunteers, receives a new treatment for the first time in people. The main questions are whether it is safe, how the body handles it and what dose makes sense. Visits can be frequent, and some studies ask you to stay overnight.
02
Phase 2
A larger group who have the condition receives the treatment, usually at one or more doses and often against a placebo. The aim is to see whether it seems to work and to keep watching for side effects.
03
Phase 3
Hundreds or more people across many sites receive either the new treatment or the one doctors use now. This is the comparison regulators rely on before approving anything, so these studies are usually long and carefully run.
04
Phase 4
The treatment is already approved and on sale. These studies follow it in everyday use, to learn about rare side effects, long-term results or how it compares with other options.

Studies that are not about medicines

Plenty of research has no phase at all. Studies of diets, exercise programs, devices, screening tests or apps are often labeled “not applicable” on the registry. They can still involve visits, tests and questionnaires, and the same rights apply to you in every one of them.

Which phase suits you?

There is no right answer. Early phases carry more unknowns, and later phases ask more of your time over months. What matters is that you understand what is being tested, what has already been learned about it, and what the study needs from you.